Correlation of bioluminescent assay of gentamicin in serum with agar diffusion assay, latex agglutination inhibition card test, enzyme immunoassay, and fluorescence immunoassay.
AUTOR(ES)
Nilsson, L
RESUMO
An improved bioluminescent assay of gentamicin in serum, based on the dose-dependent effect of the agent on the accumulation of extracellular ATP in Escherichia coli LU 14 cultures, is presented. The accuracy of the bioluminescent assay of gentamicin, expressed as the mean coefficient of variation over the therapeutic range, was 2.8%. Corresponding figures for an agar diffusion assay, a latex agglutination inhibition card test, an enzyme immunoassay, and a fluorescence immunoassay were 6.4, 17.5, 4.2, and 9.4%, respectively. All of the methods correlated well (r = 0.926 to 0.976), with the possible exception of the card test (r = 0.777 to 0.841). The bioluminescent assay requires only 1 microliter of serum, which allows for capillary sampling, and results are available within 75 min.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=271337Documentos Relacionados
- Comparison of the latex agglutination test with the hemagglutination inhibition test, enzyme-linked immunosorbent assay, and neutralization test for detection of antibodies to rubella virus.
- Latex agglutination inhibition card test for gentamicin assay: clinical evaluation and comparison with radioimmunoassay and bioassay.
- Performance characteristics of bioassay, radioenzymatic assay, homogeneous enzyme immunoassay, and high-performance liquid chromatographic determination of serum gentamicin.
- Evaluation of a new latex agglutination inhibition card test for determining serum gentamicin levels.
- Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status.
